Inspire Medical Systems Inc (INSP) Stock Forecast & Price Target
Inspire Medical Systems Inc · NYSE
$62.24-0.84 (-1.33%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 15 firms covering Inspire Medical Systems Inc, 4 rate it Buy or better, 10 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets range widely, $39.00 to $85.00 (about 2.2x), a sign of real disagreement on valuation. The average target of $59.85 sits 4% below the current $62.24. Sentiment has cooled somewhat, with Sell ratings rising from 0 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.91 next quarter toward $1.54 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS15 ratings
Moderate Buy
Strong Buy00%
Buy427%
Hold1067%
Sell17%
Strong Sell00%
Based on 15 analysts giving stock ratings to Inspire Medical Systems Inc.
As of Sep, 4 of 15 firms rate INSP a Buy (10 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
INSP EPS & revenue forecast
EPS · NEXT QUARTER
$0.91
Range $0.79 – $1.06 · 13 analysts · -45% YoY
Next period, 13 analysts expect Inspire Medical Systems Inc to earn $0.91 a share (range $0.79 – $1.06), versus $1.65 a year earlier. Full-year consensus is $1.25, growing to $1.54 the year after.
REVENUE · NEXT QUARTER
$244.4M
Range $230.5M – $251.6M · 13 analysts · -9% YoY
Revenue is expected to reach $244.4M (range $230.5M – $251.6M), -9.2% year-over-year. Full-year consensus is $853.9M, rising to $887.6M next year.
Top analysts covering Inspire Medical Systems Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INSP.
#1
Anthony Petrone
Mizuho · Rank #86
Buy
$65.00+4.4% to target
Overall win rate
46%
+ Follow
#2
Jonathan Block
Stifel · Rank #205
Buy
$75.00+20.5% to target
Overall win rate
41%
+ Follow
#3
Frank Takkinen
Lake Street · Rank #394
Buy
$150.00+141.0% to target
Overall win rate
26%
+ Follow
#4
Richard Newitter
Truist Securities
Hold
$62.00-0.4% to target
Coverage
—
+ Follow
#5
Robbie Marcus
JP Morgan
Hold
$60.00-3.6% to target
Coverage
—
+ Follow
INSP stock forecast FAQ
What is INSP's average 12-month price target?+
The 13 analysts with a live target average $59.85 for Inspire Medical Systems Inc over the next 12 months, ranging from a $85.00 high to a $39.00 low.
Is INSP stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 15 analyst ratings, 4 are Buy or Strong Buy, 10 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for INSP?+
The Street-high target is $85.00 (Oppenheimer), and the Street-low is $39.00 (UBS). The average of all 13 active targets is $59.85.
How many Wall Street analysts cover INSP?+
15 analysts have an active rating on Inspire Medical Systems Inc, and 13 firms carry a live 12-month price target.
Who is the most accurate analyst covering INSP?+
Among analysts who currently cover INSP, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #86). Their current call is Buy with a $65.00 target.
What is Inspire Medical Systems Inc's projected EPS for next quarter?+
The consensus estimate is $0.91 per share (range $0.79 – $1.06) across 13 analysts. Full-year EPS is projected at $1.25, rising to $1.54 the following year.
How much revenue is Inspire Medical Systems Inc expected to report next quarter?+
Consensus revenue is $244.4M (range $230.5M – $251.6M). Full-year revenue is projected at $853.9M, growing to $887.6M next year.
Have analysts been upgrading or downgrading INSP lately?+
As of Sep, 4 of 15 firms rate INSP a Buy (10 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INSP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
UBS
